Adapt Pharma adds new U.S. operations president

DUBLIN — Adapt Pharma on Monday announced the appointment of Mike Kelly to be president of its U.S. operations. Kelly will report to the company’s COO Eunan Maguire. 

 

Kelly has been in the industry for almost 30 years, and joins Adapt Pharma— maker of Narcan Nasal Spray (naloxone HCl) — from Covis Pharmaceuticals, where he was CEO and a member of its board. Before joining Covis, Kelly was a founding member of Azur Pharma and then SVP sales and marketing for Jazz Pharmaceuticals following a merger. 

 

“I am delighted to welcome Mike to Adapt Pharma.  Mike has established a highly successful track record in leadership roles in specialty pharmaceuticals,” Adapt Pharma CEO Seamus Mulligan. “His experience will be of great value as Adapt Pharma expands its commercial presence, starting with the launch of Narcan Nasal Spray.”